BCL2 and gastric cancer: Network topology analysis identified 4 key gene targets (AKT1, BCL2, TP53, and CASP3) along with 5 critical active compounds (Calycosin, Glycitein, Liquiritigenin, Hesperetin, and Eriodictyol) of SQWCF relevant to GC treatment.